Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Ovarian Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Lung Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Melanoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Tobacco Use Disorder 1Recurrence 1Precancerous Conditions 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Hirschsprung Disease 1Glioma 1Ganglion Cysts 1Gallbladder Neoplasms 1Endometrial Neoplasms 1

Interventions

Tamoxifen 3Neoadjuvant Therapy 2Amplified Fragment Length Polymorphism Analysis 2Ultrasonography 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mammography 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1Fulvestrant 1DNA Methylation 1Chemotherapy, Adjuvant 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Intraductal, Noninfiltrating × Immunohistochemistry × Clear all
NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

National Cancer Institute (NCI)

Phase NA Unknown
30 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡